論診断法各Ⅰ FRQ-D1 131 8） Zhang Y, Wang F, Ning N, et al. Patterns of circulat-ing tumor cells identified by CEP8, CK and CD45 in pancreatic cancer. Int J Cancer 2015; 136: 1228—33. 9） Rhim AD, Thege FI, Santana SM, et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology 2014; 146: 647—51. 10） Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 2015; 25: 981—4. 11） Kawai M, Fukuda A, Otomo R, et al. Early detection of pancreatic cancer by comprehensive serum miR-NA sequencing with automated machine learning. Br J Cancer 2024; 131: 1158—68. 4） Mehta KY, Wu HJ, Menon SS, et al. Metabolomic bio-markers of pancreatic cancer: a meta—analysis study. Oncotarget 2017; 8: 68899—915. 5） Zhu Y, Zhang H, Chen N, et al. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta—analysis. Medicine 2020; 99: e18581. 6） Patel N, Petrinic T, Silva M, et al. The Diagnostic Accuracy of Mutant KRAS Detection from Pancre-atic Secretions for the Diagnosis of Pancreatic Can-cer: A Meta—Analysis. Cancers（Basel）2020; 12: 2353. 7） Zhao R, Han Z, Zhou H, et al. Diagnostic and prog-nostic role of circRNAs in pancreatic cancer: a meta—analysis. Front Oncol 2023; 13: 1174577.
元のページ ../index.html#12